Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

161 projects found matching your search criteria :

  1. Development and evaluation of a new type of wound healing stimulators based on binding loops of the PDGF and VEGF growth...

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Przemysław Karpowicz

    Uniwersytet Gdański, Wydział Chemii

  2. New biomimetic 3D materials for potential use in advanced therapies of bone tissue diseases - 3D BioBone

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Joanna Krystyna Kolmas

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

  3. Metallacarborane-peptide amphiphiles as a new strategy in the fight against multidrug-resistant Gram-negative bacteria

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Krzysztof Konrad Fink

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  4. Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evalu...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Magdalena Wujak

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

  5. Targeting enzymes of the parasite's purine salvage pathway as a new approach to combat H. pylori infections, including t...

    Call: OPUS 26 , Panel: NZ1

    Principal investigator: prof. Maria Agnieszka Bzowska

    Uniwersytet Warszawski, Wydział Fizyki

  6. Synthesis and application of new mixed-mode materials to study the metabolism of drugs used in Poland for the treatment ...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Sylwia Studzińska

    Uniwersytet Mikołaja Kopernika, Wydział Chemii

  7. A new generation of scaffolds based on curdlan and whey protein isolate obtained by electrospinning for the treatment of...

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Katarzyna Klimek

    Uniwersytet Medyczny w Lublinie

  8. The role of free fatty acid receptors in pathophysiology of the functional gastrointestinal tract disorders: new therapi...

    Call: PRELUDIUM BIS 5 , Panel: NZ7

    Principal investigator: dr hab. Maciej Stanisław Sałaga

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  9. Unraveling protease activation in stimulated CAR-T cells to identify new biomarkers for assessing their clinical efficac...

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: dr hab. Małgorzata Firczuk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  10. Do metal nanoparticles affect the biosynthesis of bioactive plant metabolites? - studies on an in vitro culture model of...

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Szopa

    Uniwersytet Jagielloński, Collegium Medicum

  11. Targeting the serotonin 5-HT7 receptor in a search for new strategies of mental disorders treatment

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Patryk Pyka

    Uniwersytet Jagielloński, Collegium Medicum

  12. Research on the preparation of new, hydrogel nanosystems for targeted therapy of colorectal cancer

    Call: SONATA 18 , Panel: NZ7

    Principal investigator: dr Urszula Helena Piotrowska

    Warszawski Uniwersytet Medyczny

  13. Step beyond classical lipophilicity - modeling of phospholipids affinity using immobilized artificial membranes chromato...

    Call: SONATA 18 , Panel: NZ7

    Principal investigator: dr hab. Krzesimir Ciura

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  14. Exploring the unknown drug-like chemical space: new classes of sulfoximine derivatives and their biological activities.

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: prof. Maciej Filip Dawidowski

    Warszawski Uniwersytet Medyczny

  15. Identification of new biofilm-associated genes of Campylobacter jejuni.

    Call: PRELUDIUM BIS 4 , Panel: NZ7

    Principal investigator: dr hab. Ewa Wałecka-Zacharska

    Uniwersytet Przyrodniczy we Wrocławiu, Wydział Medycyny Weterynaryjnej

  16. Brain cytochrome P450 as a new target for the treatment of neurological and psychiatric diseases. Studies with human neu...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: prof. Władysława Anna Daniel

    Instytut Farmakologii PAN

  17. The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic ...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: dr Katarzyna Anna Szczepańska

    Instytut Farmakologii PAN

  18. Partial agonists of alpha-2 adrenoceptors as new perspective of the effective and safe in reducting body weight and obes...

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: dr Magdalena Bogumiła Dudek

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  19. New positive allosteric modulators of EAAT2 glutamate transporter as candidates for treatment of neurological and psychi...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: prof. Krzysztof Tomasz Kamiński

    Uniwersytet Jagielloński, Collegium Medicum

  20. Selective modulation of PPARγ signaling as a new therapeutic strategy for Alzheimer's disease

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Karolina Barbara Przepiórska-Drońska

    Instytut Farmakologii PAN

  21. The application of artificial intelligence to the discovery of new natural drugs with mechanisms aimed at lowering free ...

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Maciej Spiegel

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Farmaceutyczny

  22. Electrospun nanofiber-based nanoplatform for delivery of new nutraceutical derivatives to eliminate chemotherapy-induced...

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: dr hab. Maciej Antoni Wnuk

    Uniwersytet Rzeszowski, Collegium Medicum

  23. Biomedical and chemometric assessment of the new analytical platform in the study of endogenous substances as potential ...

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: dr Lucyna Konieczna

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

  24. New strategies in the treatment of non-small cell lung cancer based on silk nanocarriers targeting tumor vascularization

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Anna Katarzyna Florczak-Substyk

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  25. Studies on anti-inflammatory properties of GPR18 ligands and their involvement in modulation of microglia phenotypes – a...

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: prof. Katarzyna Justyna Kieć-Kononowicz

    Uniwersytet Jagielloński, Collegium Medicum

  26. New immunomodulators of BTLA-HVEM complex as potential therapeutics in systemic lupus erythematosus

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: dr hab. Anna Wardowska

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  27. New strategies in the pharmacotherapy of neuropathic pain based on modulation of the chemokine system and its influence ...

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: prof. Joanna Gabriela Mika

    Instytut Farmakologii PAN

  28. New post-treatment strategy against stroke and perinatal asphyxia – a novel approach based on a selective activation of ...

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Agnieszka Wnuk

    Instytut Farmakologii PAN

  29. The role of intestinal CYP2E1 in pathophysiology of the gastrointestinal tract disorders: new therapies for leaky gut sy...

    Call: PRELUDIUM BIS 3 , Panel: NZ7

    Principal investigator: dr hab. Maciej Stawnisław Sałaga

    Uniwersytet Medyczny w Łodzi

  30. New synthetic resveratrol derivatives with potential anti-ageing and anti-cancer properties

    Call: PRELUDIUM 2 , Panel: NZ7

    Principal investigator: dr Justyna Mikuła-Pietrasik

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski II

  31. New graphene-based approach targeting the prion-like propagation of α-synuclein in Parkinson's disease.

    Call: SONATA BIS 11 , Panel: NZ7

    Principal investigator: dr hab. Małgorzata Kujawska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  32. New type of analogs and conjugates of folic acid with potential therapeutic applicaton in treatment of hormone-dependent...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Olga Ciupak

    Politechnika Gdańska, Wydział Chemiczny

  33. New 3-methoxypropanamide derivatives in search of effective substances for the treatment of neurological diseases - epil...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Marcin Konrad Jakubiec

    Uniwersytet Jagielloński, Collegium Medicum

  34. Development of new implantable drug forms, biodegradable nanofibers containing selected betulin derivatives in order to ...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Janusz Edward Kasperczyk

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Farmaceutycznych w Sosnowcu

  35. The development of the new safe and controlled anticoagulant therapy with the use of cationically-modified polymers in t...

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: dr hab. Andrzej Mogielnicki

    Uniwersytet Medyczny w Białymstoku, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

  36. New antimycotic polycations - synthesis, chemical characterization, toxicity and antifungal spectrum

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: dr Kamil Krzysztof Kamiński

    Uniwersytet Jagielloński, Wydział Chemii

  37. Selective inhibitors of γ-aminobutyric acid (GABA) transporter subtype 3 (GAT3) as a new pharmacological tools and a cha...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: dr Dawid Marcin Panek

    Uniwersytet Jagielloński, Collegium Medicum

  38. A new class of antimicrobial compounds. Design, synthesis and study of the mechanism of action.

    Call: PRELUDIUM BIS 2 , Panel: NZ7

    Principal investigator: dr hab. Sylwia Anna Rodziewicz-Motowidło

    Uniwersytet Gdański, Wydział Chemii

  39. New generation teranostatic nanocarriers for detection, diagnosis andneuroprotective treatment of ischemic stroke brain ...

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: prof. Piotr Warszyński

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

  40. Influence of the route of administration of new psychoactive substances on their metabolic profile

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: dr Magdalena Anna Popławska

    Narodowy Instytut Leków

  41. A new approach to imaging and rapid microbiome identification in evaluation radiotherapy effects

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: dr hab. Dorota Katarzyna Gabryś

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

  42. The study on the molecular mechanisms of cytotoxic activity of new compounds ZOT5-1-Me and ZOT5-1-Et in an experimental ...

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: dr Paulina Anna Tokarz

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  43. New therapies of opioid use disorder

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: dr Wojciech Barnaba Solecki

    Uniwersytet Jagielloński, Wydział Zarządzania i Komunikacji Społecznej

  44. New 5-HT6 receptor ligands from the group of sulfonamide derivatives of cyclic arylguanidines in the treatment of gliobl...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: dr Przemysław Patryk Zaręba

    Politechnika Krakowska im. Tadeusza Kościuszki, Wydział Inżynierii i Technologii Chemicznej

  45. Photodynamic therapy combined with PD-1/PD-L1 blockade immunotherapy: new possibilities for the treatment of immunogenic...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: dr hab. Janusz Marcin Dąbrowski

    Uniwersytet Jagielloński, Wydział Chemii

  46. Dual CBR1-AKR1C3 inhibitors as a new approach to improve effectiveness and safety of anthracycline therapy.

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Marek Andrzej Jamrozik

    Uniwersytet Jagielloński, Collegium Medicum

  47. New multifunctional drug-like ligands focusing on molecular targets associated with the symptoms and causes of Alzheimer...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Anna Marta Pasieka

    Uniwersytet Jagielloński, Collegium Medicum

  48. New steroid sulfatase inhibitors based on 1,2,4-oxadiazole sulfamate derivatives

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Karol Andrzej Biernacki

    Politechnika Gdańska, Wydział Chemiczny

  49. Processing fluid: A new laboratory tool for diagnostic and basic investigation

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Hanna Marta Turlewicz-Podbielska

    Uniwersytet Przyrodniczy w Poznaniu, Wydział Medycyny Weterynaryjnej i Nauk o Zwierzętach

  50. New iron chelators from thiosemicarbazone group in photodynamic therapy

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Robert Bogumił Gawecki

    UNIWERSYTET ŚLĄSKI, Wydział Nauk Ścisłych i Technicznych

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy